Patents Assigned to Transcend Medical, Inc.
-
Patent number: 9398977Abstract: Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.Type: GrantFiled: August 22, 2014Date of Patent: July 26, 2016Assignee: Transcend Medical, Inc.Inventors: Eugene de Juan, Jr., Stephen Boyd, Mark E. Deem, Hanson S. Gifford, III, Dan Rosenman
-
Patent number: 9351873Abstract: Disclosed are devices and methods of treating an ocular disorder including forming a self-sealing incision in a cornea into an anterior chamber of an eye; introducing through the incision a fluid drainage tube having a distal end, a proximal end and a longitudinal, internal lumen extending through the fluid drainage tube, wherein at least the proximal end passes through the anterior chamber; and implanting the distal end of the fluid drainage tube in fluid communication with the suprachoroidal space such that the proximal end of the fluid drainage tube remains in fluid communication with the anterior chamber.Type: GrantFiled: March 6, 2014Date of Patent: May 31, 2016Assignee: Transcend Medical, Inc.Inventor: Minas Theodore Coroneo
-
Patent number: 9241832Abstract: A delivery system is disclosed which can be used to deliver an ocular implant into a target location within the eye via an ab interno procedure. In some embodiments, the implant can provide fluid communication between the anterior chamber and the suprachoroidal or supraciliary space while in an implanted state. The delivery system can include a proximal handle component and a distal delivery component. In addition, the proximal handle component can include an actuator to control the release of the implant from the delivery component into the target location in the eye.Type: GrantFiled: April 18, 2013Date of Patent: January 26, 2016Assignee: Transcend Medical, Inc.Inventors: Michael Schaller, David Lari, Luke Clauson, Nathan White, Richard S. Lilly, Matthew Newell, Iqbal Ike K. Ahmed
-
Patent number: 9226658Abstract: This disclosure relates generally to methods and devices for use in viewing and positioning an eye with a gonio lens system, such as during ocular exams and ocular surgeries. Some embodiments of the gonio lens system can include a gonio lens for viewing one or more tissues and structures of the eye. In addition, the gonio lens system can include one or more positioning features for controlling movement positioning of the eye.Type: GrantFiled: October 6, 2014Date of Patent: January 5, 2016Assignee: Transcend Medical, Inc.Inventors: Steven John, Richard S. Lilly, Luke Clauson, Steven Vold, Brian Walsh
-
Patent number: 9216107Abstract: Described herein are delivery devices and methods of using the devices for delivering an ocular implant into a suprachoroidal space without use of a goniolens. The delivery device includes a handle including a channel extending from a proximal end of the handle to a distal end of the handle, an applier coupled to the handle, the applier including a blunt distal tip and an elongate, flexible wire insertable through a fluid channel of an ocular implant, and a fiber optic image bundle reversibly inserted through the channel such that the fiber optic image bundle extends to a region proximal to the blunt distal tip of the applier.Type: GrantFiled: January 7, 2015Date of Patent: December 22, 2015Assignee: Transcend Medical, Inc.Inventors: Thomas A. Silvestrini, Richard S. Lilly
-
Patent number: 9155656Abstract: A delivery system is disclosed which can be used to deliver an ocular implant into a target location within the eye via an ab interno procedure. In some embodiments, the implant can provide fluid communication between the anterior chamber and the suprachoroidal or supraciliary space while in an implanted state. The delivery system can include a proximal handle component and a distal delivery component. In addition, the proximal handle component can include an actuator to control the release of the implant from the delivery component into the target location in the eye.Type: GrantFiled: February 10, 2014Date of Patent: October 13, 2015Assignee: Transcend Medical, Inc.Inventors: Michael Schaller, David Lari, Luke Clauson, Nathan White, Richard S. Lilly, Matthew Newell, Iqbal Ike K. Ahmed
-
Patent number: 9089392Abstract: This disclosure relates generally to methods and devices for use in treating eye conditions with implantable drug delivery devices. One method includes introducing an implant into the suprachoroidal space, wherein the interior volume of the implant is plugged with a drug-release material comprising at least one active agent that elutes through at least one opening in the implant, wherein the drug-release material degrades from the interior volume of the implant over a period time.Type: GrantFiled: August 23, 2013Date of Patent: July 28, 2015Assignee: Transcend Medical, Inc.Inventors: Luke Clauson, Thomas A. Silvestrini, Tsontcho Ianchulev, Steven John
-
Patent number: 9084662Abstract: Disclosed are devices and methods for treatment of eye disease. The suprachoroidal space is used as a conduit within which to place a drug delivery device. One such drug delivery device may be a tube, wicking element, bioabsorbable polymer structure, or other configuration of drug delivery substrate. The delivery device may include a port on the proximal end to assist in repeat injection, and may include a reservoir to either collect flow from the aqueous to concentrate it along the length of the device, or act as a repository for injected agent.Type: GrantFiled: January 17, 2007Date of Patent: July 21, 2015Assignee: Transcend Medical, Inc.Inventors: Hanson S. Gifford, III, Angela MacFarlane, Cary Reich
-
Patent number: 8945038Abstract: A surgical technique and device wherein an indwelling tube is placed in the eye of a patient having glaucoma. The tube diverts aqueous humor from the anterior chamber to the suprachoroidal space from which it is removed by blood flowing in the choroidal and uveal tissues. This decreases the intraocular pressure.Type: GrantFiled: May 17, 2013Date of Patent: February 3, 2015Assignee: Transcend Medical, Inc.Inventor: Michael Yablonski
-
Patent number: 8932205Abstract: Described herein are delivery devices and methods of using the devices for delivering an ocular implant into a suprachoroidal space without use of a goniolens. The delivery device includes a handle including a channel extending from a proximal end of the handle to a distal end of the handle, an applier coupled to the handle, the applier including a blunt distal tip and an elongate, flexible wire insertable through a fluid channel of an ocular implant, and a fiber optic image bundle reversibly inserted through the channel such that the fiber optic image bundle extends to a region proximal to the blunt distal tip of the applier.Type: GrantFiled: January 27, 2014Date of Patent: January 13, 2015Assignee: Transcend Medical, Inc.Inventors: Thomas A. Silvestrini, Richard S. Lilly
-
Publication number: 20140364789Abstract: Disclosed are devices and methods for treatment of eye disease such as glaucoma. Implants are described herein that create a flow field, such as between the anterior chamber and either the supraciliary space or suprachoroidal space. In addition, the implant can be treated with one or more treatments, including plasma treatments, for creating a variety of surface features and characteristics. Some of the surface features and characteristics can assist in controlling tissue responses to the implanted implant, including promoting or preventing tissue proliferation.Type: ApplicationFiled: May 21, 2014Publication date: December 11, 2014Applicant: Transcend Medical, Inc.Inventor: Michael Schaller
-
Publication number: 20140323995Abstract: This disclosure relates generally to methods and devices for use in treating eye conditions. In some embodiments, a site-specific therapeutic agent is mixed with a releasing agent with a dual syringe apparatus in order to achieve homogeneity. Once mixed, the site-specific therapeutic agent and releasing agent can be either dispensed directly within an area of the eye or within an implant. The implant can be at least partially filled with the site-specific therapeutic agent and releasing agent either prior to or after implantation into the eye. Some ratios of site-specific therapeutic agents to releasing agents are disclosed which provide various releasing profiles of the site-specific therapeutic agent within the eye.Type: ApplicationFiled: April 23, 2014Publication date: October 30, 2014Applicant: TRANSCEND MEDICAL, INC.Inventors: Luke Clauson, Tsontcho Ianchulev, Nathan White, Richard S. Lilly, Matthew Newell, Michael Schaller
-
Publication number: 20140309599Abstract: This disclosure relates generally to an injection device having a plunger configured to advance a distance into a container of material, such as a viscoelastic container; a trigger mechanism configured upon an actuation of the trigger mechanism to apply a first force to a spring element; and the spring element coupled to the plunger and configured to apply a second force to the plunger and which is configured to prevent exceeding a threshold maximum force applied to the container.Type: ApplicationFiled: April 16, 2014Publication date: October 16, 2014Applicant: TRANSCEND MEDICAL, INC.Inventor: Michael Schaller
-
Patent number: 8851676Abstract: This disclosure relates generally to methods and devices for use in viewing and positioning an eye with a gonio lens system, such as during ocular exams and ocular surgeries. Some embodiments of the gonio lens system can include a gonio lens for viewing one or more tissues and structures of the eye. In addition, the gonio lens system can include one or more positioning features for controlling movement positioning of the eye.Type: GrantFiled: October 19, 2012Date of Patent: October 7, 2014Assignee: Transcend Medical, Inc.Inventors: Steven John, Richard S. Lilly, Luke Clauson, Steven Vold, Brian Walsh
-
Patent number: 8814819Abstract: Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.Type: GrantFiled: December 16, 2010Date of Patent: August 26, 2014Assignee: Transcend Medical, Inc.Inventors: Eugene De Juan, Jr., Stephen Boyd, Mark E. Deem, Hanson S. Gifford, III, Dan Rosenman
-
Patent number: 8808220Abstract: Disclosed are devices and methods of treating an ocular disorder including forming a self-sealing incision in a cornea into an anterior chamber of an eye; introducing through the incision a fluid drainage tube having a distal end, a proximal end and a longitudinal, internal lumen extending through the fluid drainage tube, wherein at least the proximal end passes through the anterior chamber; and implanting the distal end of the fluid drainage tube in fluid communication with the suprachoroidal space such that the proximal end of the fluid drainage tube remains in fluid communication with the anterior chamber.Type: GrantFiled: October 14, 2010Date of Patent: August 19, 2014Assignee: Transcend Medical, Inc.Inventor: Minas Theodore Coroneo
-
Patent number: 8801649Abstract: Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.Type: GrantFiled: October 5, 2010Date of Patent: August 12, 2014Assignee: Transcend Medical, Inc.Inventors: Eugene De Juan, Jr., Stephen Boyd, Mark E. Deem, Hanson S. Gifford, III, Dan Rosenman
-
Publication number: 20140213958Abstract: This disclosure relates generally to methods and devices for an ocular implant which can be positioned in the Schlemm's canal of a patient's eye for improving fluid flow, such as aqueous fluid, through the eye. The ocular implant can have a variety of shapes and sizes which can allow the ocular implant to be implanted in the Schlemm's canal for applying a force, including a predetermined force, along a part of the Schlemm's canal. The force applied by the ocular implant can change the shape of the Schlemm's canal which can increase the flow volume within and through the Schlemm's canal.Type: ApplicationFiled: January 24, 2014Publication date: July 31, 2014Applicant: TRANSCEND MEDICAL, INC.Inventors: Luke Clauson, Michael Schaller
-
Patent number: 8771218Abstract: Disclosed are devices and methods of treating an ocular disorder including forming a self-sealing incision in a cornea into an anterior chamber of an eye; introducing through the incision a fluid drainage tube having a distal end, a proximal end and a longitudinal, internal lumen extending through the fluid drainage tube, wherein at least the proximal end passes through the anterior chamber; and implanting the distal end of the fluid drainage tube in fluid communication with the suprachoroidal space such that the proximal end of the fluid drainage tube remains in fluid communication with the anterior chamber.Type: GrantFiled: December 17, 2010Date of Patent: July 8, 2014Assignee: Transcend Medical, Inc.Inventor: Minas Theodore Coroneo
-
Publication number: 20140188030Abstract: Disclosed are devices and methods of treating an ocular disorder including forming a self-sealing incision in a cornea into an anterior chamber of an eye; introducing through the incision a fluid drainage tube having a distal end, a proximal end and a longitudinal, internal lumen extending through the fluid drainage tube, wherein at least the proximal end passes through the anterior chamber; and implanting the distal end of the fluid drainage tube in fluid communication with the suprachoroidal space such that the proximal end of the fluid drainage tube remains in fluid communication with the anterior chamber.Type: ApplicationFiled: March 6, 2014Publication date: July 3, 2014Applicant: TRANSCEND MEDICAL, INC.Inventor: Minas Theodore Coroneo